A vaccine has been developed to help prevent the recurrence of prostate cancer, and potentially other cancers.
It’s designed to teach the immune system to recognise compounds found in prostate cancer cells and is being given to men who have already been treated for the cancer.
The vaccine is made from pieces of a protein called TARP that’s found in about 95 per cent of prostate cancers. Animal studies have shown that the protein can effectively stimulate the immune system to attack the cancer.